Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Molecular Pharmaceutics|August 30, 2019
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic DrugFederica Sodano, Loretta Lazzarato, Barbara Rolando, et al.
Chemmedchem|August 7, 2012
Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitorsMassimo Bertinaria, Mohammed Abrar Abdul Gaffar Shaikh, Carola Buccellati, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant BacteriaMatteo Bersani, Mariacristina Failla, Filippo Vascon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2022
Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extractionOmar De Bei, Marialaura Marchetti, Luca Ronda, et al.
Pharmaceutics|August 29, 2024
Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological DiseasesAnnalisa Bozza, Valentina Bordano, Arianna Marengo, et al.
European Journal of Medicinal Chemistry|August 11, 2016
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosisGuilherme Felipe Dos Santos Fernandes, Paula Carolina de Souza, Leonardo Biancolino Marino, et al.
Journal of Medicinal Chemistry|November 19, 2024
Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry PerspectiveMariacristina Failla, Maria Cristina Molaro, Marica Erminia Schiano, et al.
The FEBS Journal|April 2, 2025
First-in-class inhibitors of SbnA reduce siderophore production in Staphylococcus aureusSarah Hijazi, Monica Cozzi, Somayeh Asgharpour, et al.
Molecular Pharmaceutics|June 19, 2018
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological EvaluationsSalvatore Magliocca, Carmen De Caro, Loretta Lazzarato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 14, 2025
FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cellsBenedetta Romano, Maria Cristina Molaro, Fabio Somma, et al.
Pageof 9